INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 277 filers reported holding INTRA CELLULAR THERAPIES INC in Q1 2023. The put-call ratio across all filers is 0.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $27 | +8.0% | 400 | +10.2% | 0.00% | – |
Q1 2024 | $25 | -10.7% | 363 | -7.9% | 0.00% | – |
Q4 2023 | $28 | +55.6% | 394 | +14.2% | 0.00% | – |
Q3 2023 | $18 | -18.2% | 345 | 0.0% | 0.00% | – |
Q2 2023 | $22 | +4.8% | 345 | -9.4% | 0.00% | – |
Q1 2023 | $21 | +5.0% | 381 | 0.0% | 0.00% | – |
Q4 2022 | $20 | -99.9% | 381 | +8.2% | 0.00% | – |
Q3 2022 | $16,000 | -20.0% | 352 | 0.0% | 0.00% | – |
Q2 2022 | $20,000 | +17.6% | 352 | +27.1% | 0.00% | – |
Q1 2022 | $17,000 | +41.7% | 277 | +16.4% | 0.00% | – |
Q4 2021 | $12,000 | +20.0% | 238 | -14.7% | 0.00% | – |
Q3 2021 | $10,000 | +66.7% | 279 | +84.8% | 0.00% | – |
Q2 2021 | $6,000 | +20.0% | 151 | 0.0% | 0.00% | – |
Q1 2021 | $5,000 | 0.0% | 151 | 0.0% | 0.00% | – |
Q4 2020 | $5,000 | -44.4% | 151 | -58.5% | 0.00% | – |
Q3 2020 | $9,000 | +50.0% | 364 | 0.0% | 0.00% | – |
Q2 2020 | $6,000 | 0.0% | 364 | 0.0% | 0.00% | – |
Q1 2020 | $6,000 | -40.0% | 364 | +20.5% | 0.00% | – |
Q4 2019 | $10,000 | +400.0% | 302 | 0.0% | 0.00% | – |
Q3 2019 | $2,000 | -50.0% | 302 | 0.0% | 0.00% | – |
Q2 2019 | $4,000 | 0.0% | 302 | 0.0% | 0.00% | – |
Q1 2019 | $4,000 | +33.3% | 302 | 0.0% | 0.00% | – |
Q4 2018 | $3,000 | -57.1% | 302 | 0.0% | 0.00% | – |
Q3 2018 | $7,000 | +40.0% | 302 | 0.0% | 0.00% | – |
Q2 2018 | $5,000 | -16.7% | 302 | 0.0% | 0.00% | – |
Q1 2018 | $6,000 | – | 302 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DCF Advisers, LLC | 375,000 | $15,308,000 | 5.42% |
SILVERARC CAPITAL MANAGEMENT, LLC | 113,258 | $4,623,000 | 2.06% |
Tri Locum Partners LP | 150,783 | $6,155,000 | 2.02% |
COOPER/HAIMS ADVISORS, LLC | 61,116 | $2,495,000 | 1.64% |
Vantage Consulting Group Inc | 226,670 | $9,252,000 | 1.61% |
Nicholas Investment Partners, LP | 598,261 | $24,421,000 | 1.53% |
Bellevue Group AG | 3,609,919 | $147,357,000 | 1.44% |
GENERAL AMERICAN INVESTORS CO INC | 350,804 | $14,320,000 | 1.20% |
Rhenman & Partners Asset Management AB | 429,728 | $17,541,000 | 1.19% |
WASATCH ADVISORS LP | 6,506,789 | $265,607,000 | 1.08% |